Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Prevention of New-Onset Diabetes After Kidney Transplantation
NCT00936663Phase 4Terminated
- Sponsor
- University of Nebraska
- Start
- Jul 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in diabetes mellitus (DM), sponsored by University of Nebraska. Started Jul 2009; status: terminated.
02
Drugs
sitagliptin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00936663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936663.